Draft Genome Sequence of Mycobacterium avium 11

Michelle Yee; David Klinzing; Jun-Rong Wei; Martin Gengenbacher; Eric J Rubin; Jung-Yien Chien; Po-Ren Hsueh; Thomas Dick

doi:10.1128/genomeA.00766-17

Draft Genome Sequence of Mycobacterium avium 11

Genome Announc. 2017 Aug 10;5(32):e00766-17. doi: 10.1128/genomeA.00766-17.

Authors

Michelle Yee¹, David Klinzing², Jun-Rong Wei^{3

4}, Martin Gengenbacher^{1

5}, Eric J Rubin^{3

4}, Jung-Yien Chien⁶, Po-Ren Hsueh^{6

7}, Thomas Dick^{8

5}

Affiliations

¹ Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
² AITbiotech Singapore, Singapore, Singapore.
³ Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
⁴ Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
⁵ Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
⁶ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
⁷ Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
⁸ Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore td367@njms.rutgers.edu.

Abstract

Mycobacterium avium accounts for most lung disease caused by nontuberculous mycobacteria (NTM). The lack of effective chemotherapy calls for the discovery of new drugs. Here, we report the draft genome sequence of M. avium 11, a clinical isolate used as a screening strain for NTM-focused drug discovery.